Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 45,161 | 2,338 |
| Other current assets | 0 | 0 | 0 | 550 | 527 |
| TOTAL | $N/A | $N/A | $N/A | $45,711 | $2,865 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 7,946 | 5,728 |
| Other Non-Current Assets | 0 | 0 | 0 | 2,171 | 310 |
| TOTAL | $N/A | $N/A | $N/A | $10,117 | $6,038 |
| Total Assets | $N/A | $N/A | $N/A | $52,975 | $7,515 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 2,618 | 750 |
| Accrued Expenses | N/A | N/A | N/A | 3,387 | 1,050 |
| Other current liabilities | N/A | N/A | N/A | 717 | 650 |
| TOTAL | $N/A | $N/A | $N/A | $6,722 | $2,462 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 2,052 | 5,584 |
| TOTAL | $N/A | $N/A | $N/A | $2,052 | $5,584 |
| Total Liabilities | $N/A | $N/A | $N/A | $8,774 | $8,202 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 2 | 150 |
| Retained earnings | N/A | N/A | N/A | -59,469 | -28,005 |
| Other shareholders' equity | 0 | 0 | 0 | 102,961 | 27,165 |
| TOTAL | $N/A | $N/A | $N/A | $44,201 | $-687 |
| Total Liabilities And Equity | $0 | $0 | $0 | $52,975 | $7,515 |